Comptes Rendus Physique
ISSN 1631-0705 · Elsevier BV · France · active 2000–2026
Metrics
“Cites per paper” is a two-year cited-by rate computed from OpenAlex. It is not a Clarivate Journal Impact Factor — we neither compute nor license that metric. Citation rates differ enormously between fields, so compare within a discipline.
Indexing & access
Access status: gold. Where this comes from publisher-level signals rather than works-level data it is a heuristic — confirm on the journal’s own site, especially regarding any article processing charge.
Scope
Frequently asked
Is Comptes Rendus Physique a predatory journal?
Our screening does not flag Comptes Rendus Physique. That is not a guarantee of quality — it means the venue is not on Beall's archive (frozen since 2017) and does not match our name-pattern heuristic. It is listed in DOAJ, Scopus, Web of Science, PubMed, which is a positive signal.
Is Comptes Rendus Physique indexed in Scopus or Web of Science?
Per our venue index, Comptes Rendus Physique appears in: DOAJ, Scopus, Web of Science, PubMed. Index membership changes over time — confirm on the index's own site before relying on it.
What is Comptes Rendus Physique's impact?
Papers in Comptes Rendus Physique are cited about 1.8 times each within two years of publication, and Scimago places it in Q2, with an h-index of 92. This is not a Clarivate Journal Impact Factor — we neither compute nor license that metric — and a citation rate is a property of a field as much as of a journal.
Is Comptes Rendus Physique open access?
Our index records its access status as "gold". Where this is derived from publisher-level signals rather than works-level data it is a heuristic, so confirm on the journal's own site — particularly if an article processing charge matters to you.
Similar venues
- Chemical Society ReviewsQ1 · Royal Society of Chemistry
- Progress in Materials ScienceQ1 · Elsevier BV
- New England Journal of MedicineQ1 · Massachusetts Medical Society
- Pharmacological ReviewsQ1 · American Society for Pharmacology and Experimental Therapeutics
- Progress in Polymer ScienceQ1 · Elsevier BV
- ScienceQ1 · American Association for the Advancement of Science